Business Wire

One Banana, the Better Banana Co., Presents Corporate Sustainability Report

20.6.2020 18:32:00 EEST | Business Wire | Press release

Share

One Banana publishes its sixth Sustainability Report, which presents the results of projects, programs, and good practices that have contributed to the success of the operations and further its efforts to become a world-class company in quality, productivity, and profitability. See the One Banana Sustainability Report here.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200620005027/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

We truly believe that One Banana Makes a Difference. With the publication of its sixth Sustainability Report, One Banana reassures it’s commitment to contribute to a better world, continue and improve its position in the market, maintain competitiveness, and continue to pioneer the highest standards in the industry. (Photo: Business Wire)

One Banana aims to generate value and balance in economic growth, conservation of natural resources, and the welfare of all its stakeholders. Robert Adams, President of One Banana, said, “We are proud to be a third-generation, family-owned, vertically integrated company. All of our actions are performed with the commitment to preserve our resources and responsibly produce the highest quality bananas and ingredients from our own farms.

With a business model based on a Corporate Sustainability Strategy, One Banana has implemented actions based on initiatives proposed by the United Nations, such as the Sustainable Development Goals and the Ten Principles of Global Compact.

Some notable outstanding results for 2019 were:

  • About 20,000 hectares were conserved due to participation in landscape sustainability projects and forest area conservation programs at our plantations.
  • Innovation and investment in new product lines. The company’s focus on Banana Ingredients and farm productivity allows us to close the loop on banana surplus from farms into the production of the highest quality Puree, Flakes, and Powders.
  • Between 2014 and 2019, more than 31,000 patients including workers and community members received medical care at our Medical Center established in the southwestern region of Guatemala, as part of our Comprehensive Health Project.

The company continues to develop the highest quality standards and compliance with international certifications, basing its performance on the best agro-industrial practices and the implementation of a Corporate Sustainability Strategy at every level of the operation.

About ONE Banana:

ONE Banana is a family owned sustainable grower, shipper and distributor of tropical fruit with operations in the United States, Guatemala, Europe, Peru, and Ecuador. It has emerged as a leader in socially responsible and environmentally sustainable farming. For more information please visit: https://www.onebananas.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Javier Aguirre
Corporate Director
info@onebananas.com
(502) 2420-9600

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

European Commission (EC) Approves Henlius and Organon’s POHERDY ® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 12:30:00 EEST | Press release

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt

CORRECTING and REPLACING Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival29.4.2026 11:49:00 EEST | Press release

Headline of release dated April 27, 2026 should read: Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival The updated release reads: YOSHIHIRO SHIMAMURA, A LEADING INVESTOR IN JAPAN’S ENTERTAINMENT INDUSTRY, TO HOST WORKSHOP AT THE 2026 CANNES FILM FESTIVAL Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of

Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 11:27:00 EEST | Press release

OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,

The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 11:00:00 EEST | Press release

Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, where human creativity is renewed through technology. Leading the jury will be Gabriele Salvatores, Italian director and screenwriter known for films such as Nirvana, Siberian Education, and Napoli - New York, and Academy Award® winner for Best Foreign Language Film with Mediterraneo. Joining him on the panel for the third edit

Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company29.4.2026 11:00:00 EEST | Press release

Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/ Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system. CoreGo’s in-house private network capability, the only such offering among pure-play event technology providers in Europe, en

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye